Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

John Zajicek; Susan Ball; David Wright; Jane Vickery; Andrew Nunn; David Miller; Cano M Gomez; David McManus; Sharukh Mallik; Jeremy Hobart

doi:10.1016/S1474-4422(13)70159-5

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

John Zajicek^*, Susan Ball, David Wright, Jane Vickery, Andrew Nunn, David Miller, Cano M Gomez, David McManus, Sharukh Mallik, Jeremy Hobart

^*Corresponding author for this work

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-9
Number of pages	0
Journal	Lancet Neurology
Volume	2013
Issue number	0
DOIs	https://doi.org/10.1016/S1474-4422(13)70159-5
Publication status	Published - 13 Jul 2013

Access to Document

10.1016/S1474-4422(13)70159-5

Cite this

@article{8efe2240929844a9851a5ce27158dc69,

title = "Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial",

author = "John Zajicek and Susan Ball and David Wright and Jane Vickery and Andrew Nunn and David Miller and Gomez, {Cano M} and David McManus and Sharukh Mallik and Jeremy Hobart",

year = "2013",

month = jul,

day = "13",

doi = "10.1016/S1474-4422(13)70159-5",

language = "English",

volume = "2013",

pages = "1--9",

journal = "Lancet Neurology",

issn = "1474-4422",

number = "0",

}

TY - JOUR

T1 - Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

AU - Zajicek, John

AU - Ball, Susan

AU - Wright, David

AU - Vickery, Jane

AU - Nunn, Andrew

AU - Miller, David

AU - Gomez, Cano M

AU - McManus, David

AU - Mallik, Sharukh

AU - Hobart, Jeremy

PY - 2013/7/13

Y1 - 2013/7/13

U2 - 10.1016/S1474-4422(13)70159-5

DO - 10.1016/S1474-4422(13)70159-5

M3 - Article

SN - 1474-4422

VL - 2013

SP - 1

EP - 9

JO - Lancet Neurology

JF - Lancet Neurology

IS - 0

ER -